A New Synthetic Histone Deacetylase Inhibitor, MHY2256, Induces Apoptosis and Autophagy Cell Death in Endometrial Cancer Cells via p53 Acetylation

被引:55
|
作者
De, Umasankar [1 ]
Son, Ji Yeon [1 ]
Sachan, Richa [1 ]
Park, Yu Jin [1 ]
Kang, Dongwan [2 ]
Yoon, Kyungsil [3 ]
Lee, Byung Mu [1 ]
Kim, In Su [1 ]
Moon, Hyung Ryong [2 ]
Kim, Hyung Sik [1 ]
机构
[1] Sungkyunkwan Univ, Sch Pharm, 2066 Seobu Ro, Suwon 16419, South Korea
[2] Pusan Natl Univ, Coll Pharm, Busandaehak Ro 63 Beon Gil 2, Busan 46241, South Korea
[3] Natl Canc Ctr, Div Translat Sci, Comparat Biomed Res Branch, 323 Ilsandong Gu, Goyang Si 10408, South Korea
基金
新加坡国家研究基金会;
关键词
histone deacetylase inhibitor; MHY2256; p53; apoptosis; autophagy; Ishikawa; endometrial cancer; SIRT1; EXPRESSION; METABOLISM; CARCINOMA; APICIDIN; ARREST;
D O I
10.3390/ijms19092743
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously discovered a novel sirtuin (SIRT) inhibitor, MHY2256, that exerts anticancer activity through p53 acetylation in MCF-7 human breast cancer cells. We investigated the anticancer activity of MHY2256 against hormone-related cancer, an endometrial cancer with a poor prognosis. The IC50 values of MHY2256 were shown to be much lower than those of salermide, a well-known SIRT inhibitor. Furthermore, MHY2256 significantly reduced the protein expression and activities of SIRT1, 2, and 3, with similar effects to salermide. Particularly, MHY2256 markedly inhibited tumor growth in a tumor xenograft mouse model of Ishikawa cancer cells. During the experimental period, there was no significant change in the body weight of mice treated with MHY2256. A detailed analysis of the sensitization mechanisms of Ishikawa cells revealed that late apoptosis was largely increased by MHY2256. Additionally, MHY2256 increased G1 arrest and reduced the number of cell cyclic-related proteins, suggesting that apoptosis by MHY2256 was achieved by cellular arrest. Particularly, p21 was greatly increased by MHY225656, suggesting that cell cycle arrest by p21 is a major factor in MHY2256 sensitization in Ishikawa cells. We also detected a significant increase in acetylated p53, a target protein of SIRT1, in Ishikawa cells after MHY2256 treatment. In a mouse xenograft model, MHY2256 significantly reduced tumor growth and weight without apparent side effects. These results suggest that MHY2256 exerts its anticancer activity through p53 acetylation in endometrial cancer and can be used for targeting hormone-related cancers.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Oleuropein Induces Apoptosis Via the p53 Pathway in Breast Cancer Cells
    Hassan, Zeinab Korany
    Elamin, Maha Hussein
    Omer, Sawsan Ali
    Daghestani, Maha Hassan
    Al-Olayan, Ebtesam Salah
    Elobeid, Mai AbdelRahman
    Virk, Promy
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (11) : 6739 - 6742
  • [22] Melatonin Induces Apoptotic Cell Death via p53 in LNCaP Cells
    Kim, Chi Hyun
    Yoo, Yeong-Min
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2010, 14 (06): : 365 - 369
  • [23] A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells
    Patra, Nabanita
    De, Umasankar
    Kim, Tae Hyung
    Lee, Young Ju
    Ahn, Mee Young
    Kim, Nam Deuk
    Yoon, Jung Hyun
    Choi, Wahn Soo
    Moon, Hyung Ryong
    Lee, Byung Mu
    Kim, Hyung Sik
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (05) : 407 - 415
  • [24] Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells
    Roy, S
    Packman, K
    Jeffrey, R
    Tenniswood, M
    CELL DEATH AND DIFFERENTIATION, 2005, 12 (05): : 482 - 491
  • [25] Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells
    S Roy
    K Packman
    R Jeffrey
    M Tenniswood
    Cell Death & Differentiation, 2005, 12 : 482 - 491
  • [26] Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis
    Huang, YH
    Tan, MJ
    Gosink, M
    Wang, KKW
    Sun, Y
    CANCER RESEARCH, 2002, 62 (10) : 2913 - 2922
  • [27] The Histone Deacetylase Inhibitor Vorinostat Induces Hyper-radiosensitivity (HRS) In P53 Wild Type Glioblastoma Cells
    Carrier, F.
    Diss, E.
    Nalabothula, N.
    Kwok, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S747 - S747
  • [28] Delphinidin induces apoptosis via cleaved HDAC3-mediated p53 acetylation and oligomerization in prostate cancer cells
    Jeong, Mi-Hyeon
    Ko, Hyeonseok
    Jeon, Hyelin
    Sung, Gi-Jun
    Park, Soo-Yeon
    Jun, Woo Jin
    Lee, Yoo-Hyun
    Lee, Jeongmin
    Lee, Sang-wook
    Yoon, Ho-Geun
    Choi, Kyung-Chul
    ONCOTARGET, 2016, 7 (35) : 56767 - 56780
  • [29] Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate
    Joseph, J
    Wajapeyee, N
    Somasundaram, K
    INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (01) : 11 - 18
  • [30] Histone deacetylase inhibitor quisinostat activates caspase signaling and upregulates p53 acetylation to inhibit the proliferation of HepG2 cells
    Li, Fengshan
    Wang, Tiegong
    Wang, Zhenyong
    Chen, Xiongfei
    Liu, Ruhai
    MOLECULAR MEDICINE REPORTS, 2017, 16 (05) : 6094 - 6101